The monthlong partial government shutdown is forcing some companies to seek alternate routes to go public while the main markets regulator is unable to greenlight IPOs, The Wall Street Journal reports. Biotechnology companies Gossamer Bio Inc. and TCR2 Therapeutics Inc. have been exploring a little-used workaround that would let them begin trading without the usual
With SEC shuttered, companies try IPO workaround
Sign up for the free Daily Report email – local news about the people, companies and issues that impact business impact business in Baton Rouge and beyond.
